Skip to main content
. 2013 Apr 12;169(1):51–68. doi: 10.1111/bph.12134

Table 3.

AMG 181 in vitro pharmacology parameters

AMG 181 assay type Species Cell type Parameter or result
Receptor binding affinity Human HuT78 cells expressing α4β7 Kd = 0.9 (0.2–2.3)a pM
Receptor binding specificity Human HEK 293 T cellsb Specific binding to α4β7
Binding to primary T cells Human CD4+CD45RA-memory T cells EC50 = 4.0 ng·mL−1 (26 pM)
Cynomolgus monkey CD4+CD28+CD95+ CM T cells EC50 = 2.6 ng·mL−1 (17 pM)
Blocking of α4β7:MAdCAM-1 binding Human CD4+CD45RA-memory T cells IC50 = 6.4 ng·mL−1 (42 pM)
Cynomolgus monkey CD4+CD28+CD95+ CM T cells IC50 = 4.5 ng·mL−1 (30 pM)
Blocking of T cell adhesionc Human HuT78 cells IC50 = 1.5 ng·mL−1 (10 pM)
Human Purified T cells IC50 = 12.0 ng·mL−1 (80 pM)
Cynomolgus monkey Purified T cells IC50 = 12.6 ng·mL−1 (84 pM)
a

Optimal Kd (95% confidence interval range).

b

Transiently co-transfected with expression vectors for α4β7, α4β1 or αEβ7 subunits.

c

α4β7 : MAdCAM-1-mediated T cell adhesion.